Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study

Vivoxid Ltd63 enrolled

Overview

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Depressed Lateral Condyle Fracture Benign Bone Tumour Cavity Spinal Fusion

Interventions

Bioactive glass and/or autogenous boneDEVICE

No intervention in the current study (10-year follow-up study)

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Written informed consent obtained; Participation of previous clinical investigation with bioactive glass Exclusion Criteria: * The subject is unlikely to adhere to study procedures * Concurrent disease or condition that in the opinion of the investigator is contraindicating participation * Simultaneous participation in another medical device or investigational drug trial

Locations (1)

Turku University Hospital

Turku, Finland

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.